Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Takara Bio and CAMS to codevelop cancer immunotherapies in China

Sep. 9, 2004

Positive interim results from phase II trials of TroVax

Sep. 3, 2004

Antitumor efficacy of ABX-EGF in metastatic renal cancer

Sep. 1, 2004

Aphton seeks Canadian registration of Insegia in pancreatic cancer

Aug. 30, 2004

SGN-40 receives orphan drug designation for multiple myeloma

Aug. 26, 2004

Medarex reaches SPA agreement for phase III trial of MDX-010

Aug. 26, 2004

Orphan drug status for HuMax-CD4

Aug. 24, 2004

Viragen updates Multiferon progress

Aug. 24, 2004

Bispecific antibody targets EGFR-positive bile duct carcinoma

Aug. 19, 2004

New phase II study for HuMax-CD4 in non-cutaneous T-cell lymphoma

Aug. 18, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 16, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...